findmyKOL
Clinical trialNCT06283251RecruitingInterventional

PediRISE Feasibility

SponsorDana-Farber Cancer InstituteEnrollment40DisparitiesFinancial HardshipFinancial StressPediatric Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: * PediRISE Program Group * Usual Care Group

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California San Francisco

    San Francisco, California, United States

    Recruiting
  • Boston Children'S Hospital

    Boston, Massachusetts, United States

    Kira Bona, MD, MPH
    Recruiting
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Kira Bona, MD, MPH
    Recruiting
  • Columbia University Medical Center

    New York, New York, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 May 2024
Primary completion
30 Jun 2027
Completion
30 Jun 2027
Last update posted
10 Feb 2026
Registered enrollment
40
Registry id
NCT06283251

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.